News
Illumina sees new pharma interest, even as its business suffers several hits from NIH funding and a DOJ settlement.
President Trump is moving forward on a new suite of tariff rates with an approach focused on grouping countries into tiers — a change from a previous approach of simply looking at the trade deficit.
23m
Daily Times on MSNGilgit-Baltistan traders block China trade over taxesTraders in Gilgit-Baltistan (GB) continued their protest for the 24th day, blocking the trade route to China. The Karakoram ...
National Security Journal on MSN44m
The Big India F-35 Fighter Deal Looks DeadIndia has confirmed there are no ongoing discussions to purchase the F-35 fighter, a sharp reversal from President Trump’s offer just months ago. -This about-face comes amid a rapid downturn in ...
BlackRock Health Sciences Term Trust (BMEZ) exposes investors to life science companies but the performance has been flawed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results